Factors that influence oral bioavailability; a cathepsin K inhibitor for human studies.
Veber
Daniel F
DF
Drug Discovery Consultant, 290 Batleson Rd. Ambler, PA 19002, USA.
D000284:Administration, Oral; D001682:Biological Availability; D056657:Cathepsin K; D002403:Cathepsins / Q000037:antagonists & inhibitors*; D018360:Crystallography, X-Ray; D015853:Cysteine Proteinase Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans
D015853:Cysteine Proteinase Inhibitors; D002403:Cathepsins; C534130:CTSK protein, human; D056657:Cathepsin K